Reversible cardiac function and left ventricular hypertrophy in a Chinese man with mitochondrial myopathy: a case report.
Heart failure
Left ventricular hypertrophy
Mitochondrial myopathy
Pulmonary artery hypertension
Respiratory failure
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
15 09 2023
15 09 2023
Historique:
received:
10
08
2023
accepted:
24
08
2023
medline:
18
9
2023
pubmed:
16
9
2023
entrez:
15
9
2023
Statut:
epublish
Résumé
Mitochondrial myopathies (MMs) are a group of multi-system diseases caused by abnormalities in mitochondrial DNA (mtDNA) or mutations of nuclear DNA (nDNA). The diagnosis of mitochondrial myopathy (MM) is reliant on the combination of history and physical examination, muscle biopsy, histochemical studies, and next-generation sequencing. Patients with MMs have diverse clinical manifestations. In the contemporary literature, there is a paucity of reports on cardiac structure and function in this rare disease. We report a Chinese man with MM accompanied with both acute right heart failure and left ventricular hypertrophy. A 49-year-old man presented with clinical features suggestive of MM, i.e., ophthalmoparesis, weakness of the pharyngeal and extremity muscles, and respiratory muscles which gradually progressed to respiratory insufficiency. He had a family history of mitochondrial myopathy. He had increased levels of serum creatine kinase and lactate. Muscle biopsy of left lateral thigh revealed 8% ragged red fibers (RRF) and 42% COX-negative fibers. Gene sequencing revealed a novel heterozygote TK2 variant (NM_001172644: c.584T>C, p.Leu195Pro) and another heterozygous variant (NM_004614.4:c.156+958G>A; rs1965661603) in the intron of TK2 gene. Based on these findings, we diagnosed the patient as a case of MM. Echocardiography revealed right heart enlargement, pulmonary hypertension, left ventricular hypertrophy, and thickening of the main pulmonary artery and its branches. The patient received non-invasive ventilation and coenzyme Q10 (CoQ10). The cardiac structure and function were restored at 1-month follow-up. This is the first report of reversible cardiac function impairment and left ventricular hypertrophy in a case of adult-onset MM, nocturnal hypoxia is a potential mechanism for left ventricular hypertrophy in patients with MM.
Sections du résumé
BACKGROUND
Mitochondrial myopathies (MMs) are a group of multi-system diseases caused by abnormalities in mitochondrial DNA (mtDNA) or mutations of nuclear DNA (nDNA). The diagnosis of mitochondrial myopathy (MM) is reliant on the combination of history and physical examination, muscle biopsy, histochemical studies, and next-generation sequencing. Patients with MMs have diverse clinical manifestations. In the contemporary literature, there is a paucity of reports on cardiac structure and function in this rare disease. We report a Chinese man with MM accompanied with both acute right heart failure and left ventricular hypertrophy.
CASE PRESENTATION
A 49-year-old man presented with clinical features suggestive of MM, i.e., ophthalmoparesis, weakness of the pharyngeal and extremity muscles, and respiratory muscles which gradually progressed to respiratory insufficiency. He had a family history of mitochondrial myopathy. He had increased levels of serum creatine kinase and lactate. Muscle biopsy of left lateral thigh revealed 8% ragged red fibers (RRF) and 42% COX-negative fibers. Gene sequencing revealed a novel heterozygote TK2 variant (NM_001172644: c.584T>C, p.Leu195Pro) and another heterozygous variant (NM_004614.4:c.156+958G>A; rs1965661603) in the intron of TK2 gene. Based on these findings, we diagnosed the patient as a case of MM. Echocardiography revealed right heart enlargement, pulmonary hypertension, left ventricular hypertrophy, and thickening of the main pulmonary artery and its branches. The patient received non-invasive ventilation and coenzyme Q10 (CoQ10). The cardiac structure and function were restored at 1-month follow-up.
CONCLUSIONS
This is the first report of reversible cardiac function impairment and left ventricular hypertrophy in a case of adult-onset MM, nocturnal hypoxia is a potential mechanism for left ventricular hypertrophy in patients with MM.
Identifiants
pubmed: 37715114
doi: 10.1186/s12872-023-03444-z
pii: 10.1186/s12872-023-03444-z
pmc: PMC10503081
doi:
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
464Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Front Neurol. 2020 Sep 08;11:1000
pubmed: 33013660
J Bras Pneumol. 2020;46(6):e20190136
pubmed: 32696937
BMJ Open Respir Res. 2020 Nov;7(1):
pubmed: 33246973
Am J Respir Crit Care Med. 2020 Jan 15;201(2):148-157
pubmed: 31513751
Circulation. 1993 Jan;87(1):247-60
pubmed: 8419014
Neurotherapeutics. 2018 Oct;15(4):943-953
pubmed: 30406383
Orphanet J Rare Dis. 2016 Jul 29;11(1):105
pubmed: 27473873
Minerva Endocrinol. 2019 Jun;44(2):159-168
pubmed: 30482010
Neurol Genet. 2016 Sep 14;2(5):e95
pubmed: 27660820
Front Physiol. 2021 Feb 12;11:608347
pubmed: 33643059
Neurol Clin. 2014 Aug;32(3):777-99, ix
pubmed: 25037090
Orphanet J Rare Dis. 2019 May 6;14(1):100
pubmed: 31060578
Mitochondrion. 2021 Mar;57:205-212
pubmed: 33486010
Zhonghua Er Ke Za Zhi. 2019 Mar 2;57(3):211-216
pubmed: 30818899
Respir Med. 2020 Sep;171:106099
pubmed: 32829182
Curr Opin Neurol. 2019 Oct;32(5):715-721
pubmed: 31408013